Your browser doesn't support javascript.
loading
Elevated plasma level of the glycolysis byproduct methylglyoxal on admission is an independent biomarker of mortality in ICU COVID-19 patients.
Alomar, Fadhel A; Alshakhs, Marai N; Abohelaika, Salah; Almarzouk, Hassan M; Almualim, Mohammed; Al-Ali, Amein K; Al-Muhanna, Fahad; Alomar, Mohammed F; Alhaddad, Mousa J; Almulaify, Mohammed S; Alessa, Faisal S; Alsalman, Ahmed S; Alaswad, Ahmed; Bidasee, Sean R; Alsaad, Hassan A; Alali, Rudaynah A; AlSheikh, Mona H; Akhtar, Mohammed S; Al Mohaini, Mohammed; Alsalman, Abdulkhaliq J; Alturaifi, Hussain; Bidasee, Keshore R.
Afiliação
  • Alomar FA; Department of Pharmacology and Toxicology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P. O. Box 1982, Dammam, 31441, Saudi Arabia. falomar@iau.edu.sa.
  • Alshakhs MN; Department of Internal Medicine, Dammam Medical Complex, Dammam, Saudi Arabia.
  • Abohelaika S; Clinical Pharmacology Department, Qatif Central Hospital, Ministry of Health, Qatif, Saudi Arabia.
  • Almarzouk HM; Department of Internal Medicine, Dammam Medical Complex, Dammam, Saudi Arabia.
  • Almualim M; Intenstive Care Unit, Qatif Central Hospital, Ministry of Health, Qatif, Saudi Arabia.
  • Al-Ali AK; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • Al-Muhanna F; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • Alomar MF; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • Alhaddad MJ; Department of Internal Medicine, Dammam Medical Complex, Dammam, Saudi Arabia.
  • Almulaify MS; Department of Internal Medicine, Dammam Medical Complex, Dammam, Saudi Arabia.
  • Alessa FS; Department of Internal Medicine, Dammam Medical Complex, Dammam, Saudi Arabia.
  • Alsalman AS; Department of Internal Medicine, Dammam Medical Complex, Dammam, Saudi Arabia.
  • Alaswad A; Clinical Pharmacology Department, Qatif Central Hospital, Ministry of Health, Qatif, Saudi Arabia.
  • Bidasee SR; Departments of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
  • Alsaad HA; Department of Pharmacology and Toxicology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P. O. Box 1982, Dammam, 31441, Saudi Arabia.
  • Alali RA; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • AlSheikh MH; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • Akhtar MS; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • Al Mohaini M; Basic Sciences Department, College of Applied Medical Sciences, King Saud Bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Al Ahsa, 31982, Saudi Arabia.
  • Alsalman AJ; Department of Clinical Pharmacy, Faculty of Pharmacy, Northern Border University, Rafha, Saudi Arabia.
  • Alturaifi H; King Fahad Hospital Hofuf, Alahsa, Saudi Arabia.
  • Bidasee KR; Departments of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. kbidasee@unmc.edu.
Sci Rep ; 12(1): 9510, 2022 06 09.
Article em En | MEDLINE | ID: mdl-35680931
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Unidades de Terapia Intensiva Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Unidades de Terapia Intensiva Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article